Cargando…
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Na(v)1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
BACKGROUND: Small fiber neuropathy generally leads to considerable pain and autonomic symptoms. Gain-of-function mutations in the SCN9A- gene, which codes for the Na(v)1.7 voltage-gated sodium channel, have been reported in small fiber neuropathy, suggesting an underlying genetic basis in a subset o...
Autores principales: | de Greef, Bianca T. A., Merkies, Ingemar S. J., Geerts, Margot, Faber, Catharina G., Hoeijmakers, Janneke G. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929773/ https://www.ncbi.nlm.nih.gov/pubmed/27363506 http://dx.doi.org/10.1186/s13063-016-1430-1 |
Ejemplares similares
-
Differential effect of lacosamide on Na(v)1.7 variants from responsive and non-responsive patients with small fibre neuropathy
por: Labau, Julie I R, et al.
Publicado: (2020) -
Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial
por: de Greef, Bianca T. A., et al.
Publicado: (2016) -
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
por: Brouwer, Brigitte A., et al.
Publicado: (2015) -
Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
por: Geerts, Margot, et al.
Publicado: (2021) -
Na(V)1.7: Stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus
por: Black, Joel A, et al.
Publicado: (2013)